Chronic Myelomonocytic Leukemia Terminated Phase 1 Trials for Azacitidine (DB00928)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01908387Phase 1 Study of CC-486 in Japanese Subjects With Hematological NeoplasmsTreatment